Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced today that it has formed Firma Clinical Research. The new company combines the expertise of Pharma Start and H2O Clinical, two distinguished clinical service organizations previously working in close collaboration. Built on decades of clinical development leadership and expertise, Firma Clinical supports the drug development efforts of pharmaceutical and biotech companies through advanced in-home patient visits, data management and biostatistics, medical writing, regulatory consulting, clinical pharmacology, and clinical operations.
With locations in Chicago, IL, and Baltimore, MD, Firma’s tagline, “Expert Insights, Quality Outcomes” reflects the company’s level of industry knowledge and expertise coupled with a grounding and adherence to quality certified processes and procedures. Drawing inspiration from its mission to provide a solid foundation of expert insights derived from evidence-based processes and strategic services, Firma is the force behind quality outcomes, including optimized data, patient safety, reduced time-to-market, and operational savings.